India

in page functions
[French]
India
Total population (2017) 1,342,480,790
Birth cohort (2017) 25,732,835
Surviving Infants (surviving to 1 year per year, 2017) 24,843,532
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 38/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 48/1000
Gross Nation Income (per capita US$, 2015) 1,600
Co-financing group (2017) Accelerated transition
No. of districts/territories (2016) 676

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for India

Type of support

Approvals

2001-2021 (US$)
(18 Oct 2017)

Commitments

2001-2021 (US$)
(18 Oct 2017)

Disbursements

2000-2017 (US$)
(18 Oct 2017)

% Disbursed

(18 Oct 2017)
2002 2003 2005 2006 2007 2009 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021
Total $650,087,705 $848,156,002 $527,765,003
Health system strengthening (HSS 1) $107,000,000 $107,000,000 $107,000,000 100%
Health system strengthening (HSS 2) $53,979,703 $100,000,000 $12,288,952 23%
HepB mono (NVS) $26,486,033 $26,486,033 $26,486,033 100%
Injection safety support (INS) $18,427,489 $18,427,489 $18,427,489 100%
IPV (NVS) $16,524,442 $16,524,442 $16,319,169 99%
Measles-Rubella (NVS) $127,341,015 $127,341,015 $53,197,652 42%
Penta (NVS) $265,000,000 $265,000,000 $264,904,712 100%
Pneumo (NVS) $27,952,000 $180,000,000 $28,725,473 103%
Rotavirus (NVS) $6,961,500 $6,961,500
Vaccine Introduction Grant (VIG) $415,523 $415,523 $415,523 100%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

India DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2016)

Grade of confidence


N/A
DTP3 - Official country estimates (2016) 88%
M:F sex ratio at birth (2017) 1.11
Household survey: DTP3 coverage for male (2008) 71.50%
Household survey: DTP3 coverage for female (2008) 71.40%
Household survey: Last DTP3 survey (2008) 72%
% districts achieving > 80% DTP3 coverage (2016) 69%
% districts achieving < 50% DTP3 coverage (2016) 3%
MCV WHO/UNICEF estimates (2016) 88%

Breakdown of support

Non-vaccine support Vaccine support
26% 74%
$138,131,964 $389,633,039

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to India

26 October 2017

Malawi MR 2017

24 October 2017

Bangladesh IPV PCV launch 2015

World Polio Day: Gavi's role in polio eradication

24 October marks World Polio Day, when the global community celebrates the immense progress and considers the work ahead to ensure no child suffers from polio again.

20 July 2017

Sierra Leone: vaccination card

Vaccine progress in developing countries 'in danger of stalling'

New figures show an increase in measles, pneumococcal and rotavirus vaccine coverage in developing countries, but basic vaccine coverage remains unchanged at 80%.

close icon

modal window here